Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification Exploratory analyses were performed on a data set from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results